These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25348508)

  • 1. Cysteamine (Cystagon®) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults.
    Ariceta G; Lara E; Camacho JA; Oppenheimer F; Vara J; Santos F; Muñoz MA; Cantarell C; Gil Calvo M; Romero R; Valenciano B; García-Nieto V; Sanahuja MJ; Crespo J; Justa ML; Urisarri A; Bedoya R; Bueno A; Daza A; Bravo J; Llamas F; Jiménez Del Cerro LA
    Nephrol Dial Transplant; 2015 Mar; 30(3):475-80. PubMed ID: 25348508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
    Nesterova G; Williams C; Bernardini I; Gahl WA
    Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood and illness experiences of adults with cystinosis.
    Beinart N; Hackett RA; Graham CD; Weinman J; Ostermann M
    Ren Fail; 2015 Jun; 37(5):835-9. PubMed ID: 25715639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cystinosis : Diagnosis, cystine-depleting therapy, and transition].
    Kaufeld J; Weber LT; Kurschat C; Canaan-Kuehl S; Brand E; Oh J; Pape L
    Internist (Berl); 2018 Aug; 59(8):861-867. PubMed ID: 29671012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the treatment of cystinosis.
    Schneider JA; Clark KF; Greene AA; Reisch JS; Markello TC; Gahl WA; Thoene JG; Noonan PK; Berry KA
    J Inherit Metab Dis; 1995; 18(4):387-97. PubMed ID: 7494398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate.
    Besouw M; Tangerman A; Cornelissen E; Rioux P; Levtchenko E
    Mol Genet Metab; 2012 Sep; 107(1-2):234-6. PubMed ID: 22832073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers.
    Berends CL; Pagan L; van Esdonk MJ; Klarenbeek NB; Bergmann KR; Moerland M; van der Wel V; de Visser SJ; Büller H; de Loos F; de Vries WS; Waals H; de Leede LGJ; Burggraaf J; Kamerling IMC
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00739. PubMed ID: 33764642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to cysteamine in nephropathic cystinosis: A unique electronic monitoring experience for a better understanding. A prospective cohort study: CrYSTobs.
    Gaillard S; Roche L; Lemoine S; Deschênes G; Morin D; Vianey-Saban C; Acquaviva-Bourdain C; Ranchin B; Bacchetta J; Kassai B; Nony P; Bodénan E; Laudy V; Rouges C; Zarrabian S; Subtil F; Mercier C; Cochat P; Bertholet-Thomas A
    Pediatr Nephrol; 2021 Mar; 36(3):581-589. PubMed ID: 32901297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
    Ahlenstiel-Grunow T; Kanzelmeyer NK; Froede K; Kreuzer M; Drube J; Lerch C; Pape L
    Pediatr Nephrol; 2017 Jan; 32(1):91-97. PubMed ID: 27350621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.
    Langman CB; Greenbaum LA; Sarwal M; Grimm P; Niaudet P; Deschênes G; Cornelissen E; Morin D; Cochat P; Matossian D; Gaillard S; Bagger MJ; Rioux P
    Clin J Am Soc Nephrol; 2012 Jul; 7(7):1112-20. PubMed ID: 22554716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystinosis: a new perspective.
    Veys KR; Besouw MT; Pinxten AM; Dyck MV; Casteels I; Levtchenko EN
    Acta Clin Belg; 2016 Jun; 71(3):131-7. PubMed ID: 25560059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystinosis in adults: A systemic disease].
    Servais A; Goizet C; Bertholet-Thomas A; Decramer S; Llanas B; Choukroun G; Novo R
    Nephrol Ther; 2015 Jun; 11(3):152-9. PubMed ID: 25769364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystinosis in adult and adolescent patients: Recommendations for the comprehensive care of cystinosis.
    Ariceta G; Camacho JA; Fernández-Obispo M; Fernández-Polo A; Gamez J; García-Villoria J; Lara Monteczuma E; Leyes P; Martín-Begué N; Oppenheimer F; Perelló M; Morell GP; Torra R; Santandreu AV; Güell A;
    Nefrologia; 2015; 35(3):304-21. PubMed ID: 26523297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intra-leukocyte cystine in cystinosis treated with cysteamine].
    Ged C; Jean G; Tete MJ; Broyer M; Kamoun P
    Ann Biol Clin (Paris); 1991; 49(9):482-6. PubMed ID: 1789502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topical cysteamine in nephropathic cystinosis.
    Al-Hemidan A; Shoughy SS; Kozak I; Tabbara KF
    Br J Ophthalmol; 2017 Sep; 101(9):1234-1237. PubMed ID: 28057644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.
    Nießl C; Boulesteix AL; Oh J; Palm K; Schlingmann P; Wygoda S; Haffner D; Wühl E; Tönshoff B; Buescher A; Billing H; Hoppe B; Zirngibl M; Kettwig M; Moeller K; Acham-Roschitz B; Arbeiter K; Bald M; Benz M; Galiano M; John-Kroegel U; Klaus G; Marx-Berger D; Moser K; Mueller D; Patzer L; Pohl M; Seitz B; Treikauskas U; von Vigier RO; Gahl WA; Hohenfellner K
    Mol Genet Metab; 2022 Aug; 136(4):268-273. PubMed ID: 35835062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
    Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
    Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
    Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E
    J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peculiarity of infantile cystinosis in Tunisian children].
    Jellouli M; Ben Turkia H; Abidi K; Hammi Y; Gargah T
    Pan Afr Med J; 2015; 22():348. PubMed ID: 26985266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-cysteine is associated to renal function improvement in patients with nephropathic cystinosis.
    Pache de Faria Guimaraes L; Seguro AC; Shimizu MH; Lopes Neri LA; Sumita NM; de Bragança AC; Aparecido Volpini R; Cunha Sanches TR; Macaferri da Fonseca FA; Moreira Filho CA; Vaisbich MH
    Pediatr Nephrol; 2014 Jun; 29(6):1097-102. PubMed ID: 24326786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.